Comments
Shares of Biocon will remain in focus, as they turn ex-bonus on Wednesday. That means, investors wishing to receive the bonus shares need to own the company’s shares by Tuesday. Biocon is rewarding its shareholders with a 1:1 bonus issue. For the fiscal 2018-19, the pharma major had reported a net profit of ₹70.50 crore and revenues of ₹2,884.70 crore. It may be recalled that it had rewarded its shareholders with 2:1 bonus and 1:1 bonus shares in 2017 and 2008, respectively.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.